FDA officials, drug developers discuss how to streamline safety monitoring for biologics

FDA officials, academic researchers and drug developers gathered at the FDA’s headquarters on Monday to discuss the landscape for monitoring the safety and efficacy of biologic drugs.

The FDA, in collaboration with the American Association of Pharmaceutical Scientists, held the day-long public workshop in Silver Spring, MD, to glean ways…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks